VPS13A and Choreoacanthocytosis: Our goal was to optimize a HeLa cell model of VPS13A dysfunction based on these previous observations to determine, as a proof of concept, whether compounds that modulate the endo‐lysosomal pathway could be beneficial in the treatment of ChAc.